The 1960s brought flower power and also the invention of Tamoxifen. Tamoxifen reduced breast cancer recurrence by 50%, and women everywhere rejoiced.
A small Stanford study has suggested that pregnant women who are worried about the health of their unborn child now have a new way to find out more details about Down Syndrome before deliver thanks to a new prenatal blood test. At present prenatal testing entails potentially dangerous techniques such as amniocentesis and chorionic villus sampling (CVS). In these procedures tissue is acquired by inserting a needle into the mother's uterus in order to obtain sample cells in the amniotic fluid or placenta.